Front-Line Therapy With Second-Generation Tyrosine Kinase Inhibitors in Patients With Early Chronic Phase Chronic Myeloid Leukemia: What Is the Optimal Response?

PURPOSE: The response definitions proposed by the European LeukemiaNet (ELN) are defined on the basis of imatinib front-line therapy. It is unknown whether these definitions apply to patients treated with second-generation tyrosine kinase inhibitors (TKIs). PATIENTS AND METHODS: One hundred sixty-se...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Jabbour, Elias, Kantarjian, Hagop M., O'Brien, Susan, Shan, Jianqin, Quintás-Cardama, Alfonso, Garcia-Manero, Guillermo, Rios, Mary Beth, Cortes, Jorge E.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society of Clinical Oncology 2011
Témata:
Original Reports
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3221527/
https://ncbi.nlm.nih.gov/pubmed/21990394
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2011.36.0693
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky